Skip to main content
EcoSphere News
PoliticsUnited States

Sackler Family and Purdue Pharma Reach Landmark $7.4 Billion Opioid Settlement

Family and company agree to historic deal aimed at addressing the opioid crisis.

Source: bbc.co.uk2 min read
Sackler Family and Purdue Pharma Reach Landmark $7.4 Billion Opioid Settlement
Image via bbc.co.uk

In brief

Settlement funds are designed to provide treatment and support for addiction recovery efforts across the United States.

Purdue Pharma and the Sackler family have forged a monumental agreement to resolve claims associated with the infamous painkiller OxyContin, committing up to $7.4 billion to address its role in the opioid crisis. This settlement, which marks a more than $1 billion increase compared to a previous rejected offer, aims to provide substantial financial resources for addiction treatment and prevention initiatives across the country.According to reports from the Associated Press and Reuters, the Sackler family is set to contribute up to $6.5 billion, while Purdue Pharma itself will pay $900 million. The New York Attorney General’s office expressed confidence that the settlement would be pivotal in supporting those affected by opioid addiction and helping combat the ongoing crisis.OxyContin has been closely linked with the escalation of opioid dependency in the United States since its introduction, often serving as a gateway to more potent drugs like heroin. Purdue’s controversial promotion of OxyContin is blamed for driving the surge in opioid-related fatalities over the years, with the Sackler family reportedly reaping significant financial benefits from the drug's sales.While the settlement awaits court approval and finalization of certain fundamental details, the U.S. federal government is not anticipated to contest it. Connecticut Attorney General William Tong highlighted the settlement's potential to bring a sense of closure to victims, emphasizing that the financial aspects cannot substitute the emotional and social repercussions of the crisis.Past proposals included a clause that granted immunity to the Sacklers in exchange for payments, a point of contention that ultimately led to the rejection of the previous deal. In an emotional response, one long-time recovery advocate, Kara Trainor, reflected on the widespread impact of Purdue and OxyContin: "Everything in my life is shaped by a company that put profits over human lives."The Sackler family has drawn significant public ire, and allegations suggest that they were well aware of the legal challenges surrounding the drug. Court documents indicate that they extracted around $11 billion from Purdue over the years leading up to its bankruptcy, strategically moving much of this wealth overseas, thereby complicating recovery efforts for the victims affected by the opioid epidemic.

Topics

More on this story